CDEK
← All organizations

Intra-Cellular Therapies

For profitContributed to NME

Also known as: INTRA-CELLULAR | Intra-Cellular Therapies Inc | Intra-Cellular Therapies, Inc. | INTRA-CELLULAR THERAPIES INC | Intra-Cellular Therapies, Inc. (ITI)

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 4

First clinical trial

Dec 1, 2011

First marketed drug

Dec 20, 2019

First NDA

Dec 20, 2019

Last known activity

Jan 28, 2025

Acquired by Johnson and Johnson on Jan 13, 2025

Timeline

2000s

  1. Jun 1, 2002

    Intra-Cellular Therapies— Founded

2010s

  1. Dec 20, 2019

    lumateperone— Marketing Organization

  2. Dec 20, 2019

    lumateperone— NDA Organization

2020s

  1. Jan 13, 2025

    Johnson and Johnson— Acquired By

Drugs by trial phase (5 distinct, 42 trials)

Phase 4 (1 own, 0 via acquisition)

Phase 3 (2 own, 0 via acquisition)

Phase 2 (2 own, 0 via acquisition)

Indications

Studied for

Marketed drugs (1)

Recent trials (50)

Details

Founded
New York, NY, US Jun 1, 2002
First NDA
Dec 20, 2019
Last known activity
Jan 28, 2025

Designations held

  • Fast track